ZNF582 hypermethylation as a prognostic biomarker for malignant transformation of oral lesions

Yi Chen Juan, Yee Fun Su, Chyi Huey Bai, Yen Chun Fan, Tzu Tung Kuo, Hui Hsin Ko, Hsin Hui Peng, Chun Pin Chiang, Chyng Wen Fwu, Shih Jung Cheng

研究成果: 雜誌貢獻文章同行評審

3 引文 斯高帕斯(Scopus)

摘要

Objectives: This hospital-based cohort study evaluated whether ZNF582 and PAX1 methylation levels at baseline can be used as biomarkers to identify lesions with a high potential for malignant transformation in patients with normal mucosa and oral potentially malignant disorders. Patients and methods: We recruited 171 adult patients with normal mucosa and oral potentially malignant disorders in 2012–2014. They were followed until 2017. Outcomes, including advanced histopathological findings and oral cancer occurrence, were obtained from medical charts, the Taiwan Cancer Registry, and cause-of-death data. Kaplan–Meier analysis and Cox proportional hazards regression models were used to examine the association of ZNF582 and PAX1 methylation levels at baseline with subsequent outcome occurrences. Results: After 260,192 days of follow-up, 11 cases of oral cancer and 4 cases of advanced histopathological progression occurred. Patients with higher ZNF582 and PAX1 methylation levels at baseline had a higher incidence of disease progression. After adjustment for all studied factors using Cox proportional hazards regression models, ZNF582m level (adjusted hazard ratio, 11.41; 95% CI, 2.05–63.36; p = 0.005) was the only significant and independent predictor of disease progression. Conclusions: ZNF582 hypermethylation can be an effective and noninvasive biomarker for identifying oral lesions with a high potential for malignant transformation.
原文英語
期刊Oral Diseases
DOIs
出版狀態接受/付印 - 2021

ASJC Scopus subject areas

  • 耳鼻咽喉科
  • 牙科 (全部)

指紋

深入研究「ZNF582 hypermethylation as a prognostic biomarker for malignant transformation of oral lesions」主題。共同形成了獨特的指紋。

引用此